We are pleased to share our new peer-reviewed paper, published in Value in Health: “Domains in Health Technology Assessment of Digital Health Technologies: A Mapping Review.”
Authored by Jeremy Dietz, Zoe Garrett, Lynda Ayiku, Livio Battaglia, Iga Lipska, Wija Oortwijn, Dario Sacchini, Joan Segur Ferrer, Emmanouil Tsiasiotis and Dalia Dawoud, the paper maps the health technology assessment domains used in assessing digital health technologies. In doing so, it lays the evidence base for determining which domains should be considered in the EDiHTA framework.
Across 44 documents, including published studies, HTA agency methods guidance and a sample of European digital health technology HTA reports, the review identifies 13 assessment domains. While areas such as clinical effectiveness, safety and economic aspects appear consistently, environmental, technical, legal, regulatory, and some ethical and human aspects remain inconsistently included.
The findings highlight where alignment already exists across digital health technology HTA and where further work is needed to reduce divergence in evidence expectations.
Read the paper: Value in Health | DOI: https://doi.org/10.1016/j.jval.2026.06.017
Abstract
Background
Health Technology Assessment (HTA) plays an important role in evaluating digital health technologies (DHTs) to inform decision-making. Commonly used HTA frameworks have been criticised as inadequate for assessing DHTs leading to the development of many DHT-specific HTA frameworks. The proliferation of frameworks creates a lack of clarity around evidence expectations for DHT HTA and perceptions of divergence in approach to HTA.
Objectives